{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:40:56Z","timestamp":1789886456219,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-GC-110-04"],"award-info":[{"award-number":["AS-GC-110-04"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005925","name":"Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022298","name":"Hualien Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCMF-A 106-01-08"],"award-info":[{"award-number":["TCMF-A 106-01-08"]}],"id":[{"id":"10.13039\/501100022298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022298","name":"Hualien Tzu Chi Hospital Buddhist Tzu Chi Medical Foundation","doi-asserted-by":"publisher","award":["TCRD-112-060"],"award-info":[{"award-number":["TCRD-112-060"]}],"id":[{"id":"10.13039\/501100022298","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.heliyon.2024.e41111","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T12:35:34Z","timestamp":1733834134000},"page":"e41111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Increased serum galectin-3 level is associated with endothelial dysfunction and cardiovascular events in patients with hypertension"],"prefix":"10.1016","volume":"11","author":[{"given":"Hui-Sheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-Gee","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiu-Fen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e41111_bib1","doi-asserted-by":"crossref","first-page":"3E","DOI":"10.1016\/0002-9149(92)90010-V","article-title":"Vascular effects of systemic hypertension","volume":"69","author":"Chobanian","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e41111_bib2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1161\/HYPERTENSIONAHA.114.03575","article-title":"Endothelial dysfunction and hypertension","volume":"64","author":"Brandes","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.heliyon.2024.e41111_bib3","article-title":"Endothelial dysfunction in hypertension: current concepts and clinical implications","volume":"8","author":"Gallo","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.heliyon.2024.e41111_bib4","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","article-title":"Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress","volume":"87","author":"Cai","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2024.e41111_bib5","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/ATVBAHA.114.303422","article-title":"Shear stress-initiated signaling and its regulation of endothelial function","volume":"34","author":"Zhou","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.heliyon.2024.e41111_bib6","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.ATV.0000051384.43104.FC","article-title":"Endothelial dysfunction: a marker of atherosclerotic risk","volume":"23","author":"Bonetti","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.heliyon.2024.e41111_bib7","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3346\/jkms.2015.30.9.1213","article-title":"Endothelial dysfunction: clinical implications in cardiovascular disease and therapeutic approaches","volume":"30","author":"Park","year":"2015","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.heliyon.2024.e41111_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070721","article-title":"New-onset diabetes, endothelial dysfunction, and cardiovascular outcomes in hypertensive patients: an illness-event model analysis","volume":"9","author":"Maio","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.heliyon.2024.e41111_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000785","article-title":"Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis","volume":"3","author":"Madrigal-Matute","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.heliyon.2024.e41111_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239232","article-title":"Galectin-3 in cardiovascular diseases","volume":"21","author":"Blanda","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e41111_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12933-022-01690-7","article-title":"The interplay of galectins-1, -3, and -9 in the immune-inflammatory response underlying cardiovascular and metabolic disease","volume":"21","author":"Mansour","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.heliyon.2024.e41111_bib12","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/S1462399408000719","article-title":"Galectins: structure, function and therapeutic potential","volume":"10","author":"Ri-Yao Yang","year":"2008","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.heliyon.2024.e41111_bib13","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1084\/jem.20090121","article-title":"Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response","volume":"207","author":"Markowska","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.heliyon.2024.e41111_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/978-1-4939-1396-1_29","article-title":"Analysis of the intracellular role of galectins in cell growth and apoptosis","volume":"1207","author":"Hsu","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.heliyon.2024.e41111_bib15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","article-title":"Galectin-3: a novel mediator of heart failure development and progression","volume":"11","author":"de Boer","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.heliyon.2024.e41111_bib16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3390\/cells9030689","article-title":"The galectin family as molecular targets: hopes for defeating pancreatic cancer","volume":"9","author":"Noem\u00ed Manero-Rup\u00e9rez","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.heliyon.2024.e41111_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/CIRCHEARTFAILURE.111.963637","article-title":"Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study","volume":"5","author":"Felker","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.heliyon.2024.e41111_bib18","article-title":"Prognostic value of serum galectin-3 in chronic heart failure: a meta-analysis","volume":"9","author":"Cheng","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.heliyon.2024.e41111_bib19","first-page":"219","article-title":"Prognostic value of changes in galectin-3 levels over time in patients with heart failure","volume":"6","author":"Rogier van der Velde","year":"2013","journal-title":"Circulation: Heart Fail."},{"key":"10.1016\/j.heliyon.2024.e41111_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oead020","article-title":"Risk stratification according to diastolic function indices in heart failure patients with mildly reduced or reduced ejection fraction","volume":"3","author":"Granot","year":"2023","journal-title":"Eur. Heart J. Open"},{"key":"10.1016\/j.heliyon.2024.e41111_bib21","doi-asserted-by":"crossref","first-page":"H1287","DOI":"10.1152\/ajpheart.00096.2016","article-title":"Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension","volume":"311","author":"Germ\u00e1n","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.heliyon.2024.e41111_bib22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/HYPERTENSIONAHA.115.05876","article-title":"Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension","volume":"66","author":"Ernesto Mart\u00ednez-Mart\u00ednez","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.heliyon.2024.e41111_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jcct.2008.09.001","article-title":"Relations between digital thermal monitoring of vascular function, the Framingham risk score, and coronary artery calcium score","volume":"2","author":"Ahmadi","year":"2008","journal-title":"J. Cardiovasc. Comput. Tomogr."},{"key":"10.1016\/j.heliyon.2024.e41111_bib24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1559-4572.2009.00058.x","article-title":"Vascular function measured by fingertip thermal reactivity is impaired in patients with metabolic syndrome and diabetes mellitus","volume":"11","author":"Ahmadi","year":"2009","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.heliyon.2024.e41111_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1358863X08098850","article-title":"Digital thermal monitoring of vascular function: a novel tool to improve cardiovascular risk assessment","volume":"14","author":"Gul","year":"2009","journal-title":"Vasc. Med."},{"key":"10.1016\/j.heliyon.2024.e41111_bib26","article-title":"New indices of endothelial function measured by digital thermal monitoring of vascular reactivity: data from 6084 patients registry","volume":"2016","author":"Naghavi","year":"2016","journal-title":"Int. J. Vasc. Med."},{"key":"10.1016\/j.heliyon.2024.e41111_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13080532","article-title":"Serum galectin-3 level is positively associated with endothelial dysfunction in patients with chronic kidney disease stage 3 to 5","volume":"13","author":"Hsu","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.heliyon.2024.e41111_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/978-1-4939-1396-1_29","article-title":"Analysis of the intracellular role of galectins in cell growth and apoptosis","volume":"1207","author":"Hsu","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.heliyon.2024.e41111_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1023\/B:GLYC.0000014082.99675.2f","article-title":"Extracellular functions of galectin-3","volume":"19","author":"Ochieng","year":"2002","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.heliyon.2024.e41111_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000962","article-title":"Renal handling of galectin-3 in the general population, chronic heart failure, and hemodialysis","volume":"3","author":"Meijers","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.heliyon.2024.e41111_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative stress: harms and benefits for human health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.heliyon.2024.e41111_bib32","doi-asserted-by":"crossref","first-page":"E4396","DOI":"10.1073\/pnas.1718921115","article-title":"Molecular mechanism to recruit galectin-3 into multivesicular bodies for polarized exosomal secretion","volume":"115","author":"Banfer","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e41111_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101743","article-title":"Nutrient-responsive O-GlcNAcylation dynamically modulates the secretion of glycan-binding protein galectin 3","volume":"298","author":"Mathew","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e41111_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00018-022-04623-5","article-title":"YAP-galectin-3 signaling mediates endothelial dysfunction in angiotensin II-induced hypertension in mice","volume":"80","author":"Pang","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.heliyon.2024.e41111_bib35","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1161\/ATVBAHA.123.319476","article-title":"Galectin-3 mediates vascular dysfunction in obesity by regulating NADPH oxidase 1","volume":"43","author":"Padgett","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.heliyon.2024.e41111_bib36","doi-asserted-by":"crossref","first-page":"10990","DOI":"10.1002\/jcp.27910","article-title":"Galectin-3 exacerbates ox-LDL-mediated endothelial injury by inducing inflammation via integrin \u03b21-RhoA-JNK signaling activation","volume":"234","author":"Xiumei Chen","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.heliyon.2024.e41111_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12933-015-0230-3","article-title":"Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes","volume":"14","author":"Darrow","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.heliyon.2024.e41111_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070781","article-title":"Inflammatory mechanisms contributing to endothelial dysfunction","volume":"9","author":"Theofilis","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.heliyon.2024.e41111_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1358\/dnp.2007.20.7.1183933","article-title":"The role of galectin-3 in promotion of the inflammatory response","volume":"20","author":"Liu","year":"2007","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.heliyon.2024.e41111_bib40","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.4049\/jimmunol.165.4.2156","article-title":"Human galectin-3 is a novel chemoattractant for monocytes and macrophages","volume":"165","author":"Sano","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e41111_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/ATVBAHA.107.159160","article-title":"Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction","volume":"28","author":"Marianna Papaspyridonos","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024171423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024171423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:17:32Z","timestamp":1778887052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024171423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2405844024171423"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e41111","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased serum galectin-3 level is associated with endothelial dysfunction and cardiovascular events in patients with hypertension","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e41111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e41111"}}